Case 3:13-cv-04022-JAP-DEA Document 5 Filed 06/28/13 Page 1 of 1 PageiD: 136
`
`AO 120 (Rev. 08/10)
`
`TO:
`
`Mail Stop 8
`Director of the U.S. Patent and Trademark
`Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`REPORT ON THE
`FILING OR DETERMINATION OF AN
`ACTION REGARDING A PATENT OR
`TRADEMARK
`
`In Compliance with 35 U.S. C. § 290 and/or 15 U.S. C. § 1116 you are hereby advised that a court action has been
`filed in the U.S. District Court for the District of New Jersey on the following:
`- - Trademarks or X Patents. ( __ the patent action involves 35 U.S.C. § 292.)
`
`DATE FILED
`DOCKET NO.
`3: 13-cv-04022-JAP- bJ'A8/2013
`PLAINTIFF
`ASTRAZENECA AB
`
`U.S. DISTRICT COURT
`TRENTON NJ
`DEFENDANT
`MYLAN PHARMACEUTICALS
`
`PATENTOR
`TRADEMARK NO.
`
`DATE OF PATENT
`OR TRADEMARK
`
`1 US 6,926,907 B2
`
`2 5,948,789
`
`8/9/2005
`
`9/7/1999
`
`HOLDER OF PATENT OR TRADEMARK
`
`POZEN INC.
`
`ASTRA AKTIEBOLAG
`
`3
`
`4
`
`5
`
`In the above--entitled case the followin!l natent(s)/ trademark(s) have been included:
`INCLUDED BY
`DATE INCLUDED
`
`-
`
`Amendment
`
`-
`
`Answer
`
`-
`
`Cross Bill
`
`_ Other Pleading
`
`PATENTOR
`TRADEMARK NO.
`1
`
`DATE OF PATENT
`OR TRADEMARK
`
`HOLDER OF PATENT OR TRADEMARK
`
`2
`
`3
`
`4
`
`5
`
`In the above--entitled case the followin2: decision has been rendered or iud2:ement issued:
`DECISION/JUDGEMENT
`
`CLERK
`William T. Walsh
`
`(BY) DEPUTY CLERK
`s/ JA WEIA CAMPBELL
`
`DATE
`6/28/2013
`
`Copy 1-Upon initiation of action, mail this copy to Director Copy 3-Upon termination of action, mail this copy to Director
`Copy 2-Upon ftling document adding patent(s), mail this copy to Director Copy 4--Case file copy
`
`
`
`Page 1 of 613
`
`Patent Owner Ex. 2005
`CFAD v. Pozen
`IPR2015-01680
`
`

`
`Case 3:13-cv-00091-JAP-TJB Document 3 Filed 01/07/13 Page 1 of 1 PageiD: 94
`
`AO 120 (Rev. 08/10)
`
`TO:
`
`Mail Stop 8
`Director of the U.S. Patent and Trademark
`Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`REPORT ON THE
`FILING OR DETERMINATION OF AN
`ACTION REGARDING A PATENT OR
`TRADEMARK
`
`In Compliance with 35 U.S.C. § 290 and/or 15 U.S.C. § 1116 you are hereby advised that a court action has been
`filed in the U.S. District Court for the District of New Jersey on the following:
`- - Trademarks or X Patents. ( __ the patent action involves 35 U.S.C. § 292.)
`U.S. DISTRICT COURT
`DATE FILED
`DOCKET NO.
`TRENTON NJ
`3: 13-cv-00091-J AP-T B'7 /2013
`DEFENDANT
`PLAINTIFF
`DR. REDDY'S LABORATORIES, INC.
`ASTRAZENECA AB
`
`PATENTOR
`TRADEMARK NO.
`
`DATE OF PATENT
`OR TRADEMARK
`
`HOLDER OF PATENT OR TRADEMARK
`
`1 6,926,907 B2
`
`2 5,714,504
`
`3 7,745,466 B2
`
`4 7,411,070 B2
`
`5 6,369,085
`
`8/9/2005
`
`2/3/98
`
`6/29/2010
`
`8/12/2008
`
`4/9/2002
`
`POZEN, INC.
`
`ASTRA AKTIEBOLAG
`
`ASTRAZENECA AB
`
`ASTRAZENECA AB
`
`ASTRAZENECA AB
`
`In the above--entitled case the following oatent( s )/ trademark( s) have been included:
`DATE INCLUDED
`INCLUDED BY
`
`PATENTOR
`TRADEMARK NO.
`
`DATE OF PATENT
`OR TRADEMARK
`
`HOLDER OF PATENT OR TRADEMARK
`
`-
`
`Amendment
`
`-
`
`Answer
`
`-
`
`Cross Bill
`
`_ Other Pleading
`
`1
`
`2
`
`3
`
`4
`
`5
`
`In the above--entitled case the following decision has been rendered or judgement issued:
`DECISION/JUDGEMENT
`
`CLERK
`William T. Walsh
`
`(BY) DEPUTY CLERK
`s/ KIM STILLMAN
`
`DATE
`117/2013
`
`Copy 1-Upon initiation of action, mail this copy to Director Copy 3-Upon termination of action, mail this copy to Director
`Copy 2-Upon filing document adding patent(s), mail this copy to Director Copy 4--case file copy
`
`
`
`Page 2 of 613
`
`Patent Owner Ex. 2005
`CFAD v. Pozen
`IPR2015-01680
`
`

`
`Case 3:11-cv-06348-JAP-DEA Document 6 Filed 10/31/11 Page 1 of 1 PageiD: 91
`
`AO 120 Rev. 08/10)
`
`TO:
`
`Mail Stop 8
`Director of the U.S. Patent and Trademark
`Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`REPORT ON THE
`FILING OR DETERMINATION OF AN
`ACTION REGARDING A PATENT OR
`TRADEMARK
`
`In Compliance with 35 U.S.C. § 290 and/or 15 U.S.C. § 1116 you are hereby advised that a court action has been
`filed in the U.S. District Court for the District of New Jersey on the following:
`- - Trademarks or X Patents. ( __ the patent action involves 35 U.S.C. § 292.)
`
`DATE FILED
`DOCKET NO.
`3:11-cv-06348-JAP- IJIDI\1112 0 11
`PLAINTIFF
`ASTRAZENECA AB
`
`U.S. DISTRICT COURT
`TRENTON NJ
`DEFENDANT
`ANCHEN PHARMACEUTICALS, INC.
`
`PATENTOR
`TRADEMARK NO.
`
`DATE OF PATENT
`OR TRADEMARK
`
`HOLDER OF PATENT OR TRADEMARK
`
`1 6,926,907 B2
`
`2 6,369,085 B1
`
`3 7,411,070 B2
`
`4 7,745,466 B2
`
`5
`
`8/9/2005
`
`4/9/2002
`
`9/12/2008
`
`6/29/2010
`
`POZEN INC.
`
`ASTRAZENECA AB
`
`ASTRAZENECA AB
`
`In the above--entitled case the following_n_aten~)! trademark(s1have been included:
`DATE INCLUDED
`INCLUDED BY
`
`PATENTOR
`TRADEMARK NO.
`
`DATE OF PATENT
`OR TRADEMARK
`
`HOLDER OF PATENT OR TRADEMARK
`
`-
`
`Amendment
`
`-
`
`Answer
`
`-
`
`Cross Bill
`
`_ Other Pleading
`
`1
`
`2
`
`3
`
`4
`
`5
`
`In the above--entitled case the followin2: decision has been rendered or judgement issued:
`DECISION/JUDGEMENT
`
`CLERK
`William T. Walsh
`
`(BY) DEPUTY CLERK
`s/ JA WEIA CAMPBELL
`
`DATE
`10/31/2011
`
`Copy 1-Upon initiation of action, mail this copy to Director Copy 3-Upon termination of action, mail this copy to Director
`Copy 2-Upon filing document adding patent(s), mail this copy to Director Copy 4-Case file copy
`
`
`
`Page 3 of 613
`
`Patent Owner Ex. 2005
`CFAD v. Pozen
`IPR2015-01680
`
`

`
`Case 3:11-cv-04275-JAP-DEA Document 2 Filed 07/25/11 Page 1 of 1 PageiD: 109
`
`AO 120 (Rev. 08/10)
`
`TO:
`
`Mail Stop 8
`Director of the U.S. Patent and Trademark
`Office
`P .0. Box 1450
`Alexandria, VA 22313-1450
`
`REPORT ON THE
`FILING OR DETERMINATION OF AN
`ACTION REGARDING A PATENT OR
`TRADEMARK
`
`In Compliance with 35 U.S.C. § 290 and/or 15 U.S.C. § 1116 you are hereby advised that a court action has been
`filed in the U.S. District Court for the District of New Jersey on the following:
`the patent action involves 35 U.S.C. § 292.)
`- - Trademarks or X Patents. (
`
`DOCKET NO.
`3: 11-cv-04275-JAP
`-DEA
`PLAINTIFF
`ASTRAZENECA AB
`
`DATE FILED
`7/25/2011
`
`U.S. DISTRICT COURT
`TRENTON, NJ
`
`DEFENDANT
`LUPIN LTD.
`
`PATENTOR
`TRADEMARK NO.
`
`DATE OF PATENT
`OR TRADEMARK
`
`HOLDER OF PATENT OR TRADEMARK
`
`I 5,714,504
`
`2 6,875,872
`
`3 6,369,085
`
`4 7,411,070
`
`5 7,745,466
`
`02/0311998
`
`04/05/2005
`
`04/09/2002
`
`08/12/2008
`
`06/29/2010
`
`ASTRA AKTIEBOLAG
`
`ASTRAZENECA
`
`ASTRAZENECA AB
`
`ASTRAZENECA AB
`
`In the above--entitled case the followin2: natent( s )/ trademark( s) have been included:
`DATE INCLUDED
`INCLUDED BY
`
`PATENTOR
`TRADEMARK NO.
`
`DATE OF PATENT
`OR TRADEMARK
`
`HOLDER OF PATENT OR TRADEMARK
`
`Amendment
`
`-
`
`-
`
`Answer
`
`-
`
`Cross Bill
`
`_ Other Pleading
`
`I
`
`2
`
`3
`
`4
`
`5
`
`In the above--entitled case the followin2: decision has been rendered or iud!!ement issued:
`DECISION/JUDGEMENT
`
`CLERK
`William T. Walsh
`
`(BY) DEPUTY CLERK
`s/ MURTUZA AKBARI
`
`DATE
`7/25/2011
`
`Copy 1-Upon initiation of action, mail this copy to Director Copy 3-Upon termination of action, mail this copy to Director
`Copy 2-Upon filing document adding patent(s), mail this copy to Director Copy 4-Case file copy
`
`
`
`Page 4 of 613
`
`Patent Owner Ex. 2005
`CFAD v. Pozen
`IPR2015-01680
`
`

`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`UJ\TTED STI\TES DEPA RTME'IT OF COMMERCE
`United States Patent and Trademark Office
`Adill"'· COMMISSIO'JER FOR PATENTS
`PO Box 1450
`Alexandria, Vllgmia 22313-1450
`"W'.'Iw.uspto.gov
`
`APPLICATION NUMBER
`10/158,216
`
`PATENT NUMBER
`6926907
`
`FILE WRAPPER LOCATION
`7581
`llllllllllllllllllllllll~~m~~muu~~i~lllllllllllllllllllllll
`Correspondence Address/Fee Address Change
`
`GROUP ART UNIT
`1615
`
`The following fields have been set to Customer Number 108197 on 08/28/2012
`• Correspondence Address
`• Maintenance Fee Address
`
`The address of record for Customer Number 108197 is:
`
`108197
`Parker Highlander PLLC
`1120 South Capital of Texas Highway
`Bldg. 1, Suite 200
`Austin, TX 78746
`
`PART 1 -ATTORNEY/APPLICANT COPY
`page 1 of 1
`
`
`
`Page 5 of 613
`
`Patent Owner Ex. 2005
`CFAD v. Pozen
`IPR2015-01680
`
`

`
`PTO/SB/80 {11~05)
`Approved ior use through 11/J0/2011. OMB 0651-0035
`U.S. Paten\ and Trademark Office: U.S. DEPARTMENT OF COMMERCE
`Urtder the Paper.vork Reduct1on Act of 1995, no persons are required to respond to a colleclion of informaUon unless il displays a valid OMB control number.
`
`POWER OF ATTORNEY TO PROSECUTE APPLICATIONS BEFORE THE USPTO
`
`l
`
`OR
`
`~~~~~--~·----.. _........~~
`
`108197
`
`Name
`
`Registration
`Number
`
`Name
`
`Registration
`Number
`
`I hereby revoke all previous powers of attorney given in the application identified in the attached statement under
`37 CFR 3.73(b).
`I hereby appoint:
`I
`0 Practitioners associated with the Customer Number:
`I l
`I
`I
`D Practitioner(s) named below (if more than len patent practitioners are to be named, then a customer number must be used):
`}~~~~~~~
`tilit
`1~1
`:::~-..:::: I ::..~x·
`~ I 1t *{
`
`as a!!orney(s) or agent(s) to represent the undersigned before the United States Paten! and Trademark Office (USPTO) in conneclion with
`any and aU patent applications assigned QJ.ljy to the undersigned according tc the USPTO assignment records or assignment documents
`attached to this fom1 in accordance witt", 37 CFR 3. 73(b).
`
`Please change the correspondence address for the application identified in the att<JCiled statement under 37 CFR 3. 73(b) to:
`
`[2]
`The address associated with Customer Number: I
`OR LJ Firm or
`
`Individual Name
`-
`Address
`
`City
`
`Country
`
`Telephone
`
`--------~-
`
`~--·
`
`Assignee Name and Address:
`
`..
`
`-------
`
`POZEN Inc.
`1414 Raleigh Road, Suite 400
`Chapel Hill, North Carolina 275"17
`
`108197
`
`I
`
`J~tate.
`
`~---
`
`-
`
`----------
`
`I Zip
`
`...
`
`---------------------------~--
`
`Email
`I
`
`··-l
`I
`
`-------~~d
`
`---
`
`A copy of this form, together with a statement under 37 CFR 3.73(b) (Form PTO/SB/96 or equivalent) is required to be
`filed in each application in which this form is used. The statement under 37 CFR 3.73(b) may be completed by one of
`the practitioners appointed in this fom1 if the appointed practitioner is authorized to act on behalf of the assignee,
`and must identify the application in which this Power of Attorney is to be filed.
`
`Signature
`
`Name
`
`SIGNATURE of Assigoee of Record
`The individual whose signature and tille is supplied below is authorized to act on behalf of the: assignee:
`~;: .. · /-8
`i
`_,(._/!:."'
`//;?;./~:~~:: i
`\. >'.-f ?f).·'/'?-z..<~L· ,··)
`Gilda Thomas
`Telephone
`Senior Vice President, General Counsel
`Tille
`Th1s cunec!lon of Information IS reqwred by 37 CFR 1.3 '· 1.32 and 1.33. T!ie lnforma\•on IS reqwred to obtam or retam a bromefit hy the public wll•ch 1s to f1l~ (.and
`'
`'
`by the USPTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 3"1 CFR 1.11 and 1 14 This collection is es1imated to lal<fl 3 minutes
`to complete, including gathering, preparing, and submitting the comple1ed application form to the USPTO. Timfl will vary depending upon the individual case. Any
`comments on the amount of lime you require to complete this !orm andlor suggestions for reducing this burden, should be sent to lhe Chief Information Off1.cer,
`U.S. P~tent and Trademark Office, U.S. Oepartmeni of Commerce, P.O. Box 1450, Alexandria. VA 22313~1450. 00 NOT SEND FEES OR COMPLETED
`FORMS TO THIS ADDRESS. SEND TO: Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313·1450.
`
`Date
`
`/: ........
`;' / . .:..._}
`
`'
`
`If you need assistance in completing the form, ca/11~800-PT0-9199 anc.i select option 2.
`
`
`
`Page 6 of 613
`
`Patent Owner Ex. 2005
`CFAD v. Pozen
`IPR2015-01680
`
`

`
`Electronic Acknowledgement Receipt
`
`EFSID:
`
`Application Number:
`
`13514576
`
`10158216
`
`International Application Number:
`
`Confirmation Number:
`
`5014
`
`Title of Invention:
`
`PHARMACEUTICAL COMPOSITIONS FOR THE COORDINATED DELIVERY OF
`NSAIDS
`
`First Named Inventor/Applicant Name:
`
`John R. Plachetka
`
`Customer Number:
`
`32425
`
`Filer:
`
`Steven Lee Highlander/Tressie Bates
`
`Filer Authorized By:
`
`Steven Lee Highlander
`
`Attorney Docket Number:
`
`POZN.P0004US
`
`Receipt Date:
`
`Filing Date:
`
`TimeStamp:
`
`16-AUG-2012
`
`31-MAY-2002
`
`15:27:40
`
`Application Type:
`
`Utility under 35 USC 111 (a)
`
`Payment information:
`
`Submitted with Payment
`
`I no
`
`File Listing:
`
`Document
`Number
`
`Document Description
`
`File Name
`
`File Size( Bytes)/
`Message Digest
`
`Multi
`Part /.zip
`
`Pages
`(ifappl.)
`
`851772
`
`1
`
`POZNP0004US.pdf
`
`yes
`
`2
`
`5 dc6c0e8f265 33 2 77 e651 f23f77 42237 acbf3
`288
`
`
`
`Page 7 of 613
`
`Patent Owner Ex. 2005
`CFAD v. Pozen
`IPR2015-01680
`
`

`
`Multipart Description/PDF files in .zip description
`
`Document Description
`
`Start
`
`End
`
`Assignee showing of ownership per 37 CFR 3.73(b).
`
`Power of Attorney
`
`1
`
`2
`
`1
`
`2
`
`Warnings:
`
`Information:
`
`Total Files Size (in bytes)
`
`851772
`
`This Acknowledgement Receipt evidences receipt on the noted date by the USPTO of the indicated documents,
`characterized by the applicant, and including page counts, where applicable. It serves as evidence of receipt similar to a
`Post Card, as described in MPEP 503.
`
`New A~~lications Under 35 U.S.C. 111
`If a new application is being filed and the application includes the necessary components for a filing date (see 37 CFR
`1.53(b)-(d) and MPEP 506), a Filing Receipt (37 CFR 1.54) will be issued in due course and the date shown on this
`Acknowledgement Receipt will establish the filing date of the application.
`
`National Stage of an International A~~lication under 35 U.S.C. 371
`If a timely submission to enter the national stage of an international application is compliant with the conditions of 35
`U.S.C. 371 and other applicable requirements a Form PCT/DO/E0/903 indicating acceptance of the application as a
`national stage submission under 35 U.S.C. 371 will be issued in addition to the Filing Receipt, in due course.
`
`New International A~~lication Filed with the USPTO as a Receiving Office
`If a new international application is being filed and the international application includes the necessary components for
`an international filing date (see PCT Article 11 and MPEP 181 0), a Notification of the International Application Number
`and of the International Filing Date (Form PCT/R0/1 OS) will be issued in due course, subject to prescriptions concerning
`national security, and the date shown on this Acknowledgement Receipt will establish the international filing date of
`the application.
`
`
`
`Page 8 of 613
`
`Patent Owner Ex. 2005
`CFAD v. Pozen
`IPR2015-01680
`
`

`
`PTO/SB/96 (07-09)
`Approved for use through 07/31/2012. OMB 0651·0031
`U.S. Patent and Trademark Off1ce; U.S. DEPARTMENT OF C:OMMERCE
`Under the Paperwork Reduction Act of 1995. no persons are reqwed to respond to a collection of information unless it displays a valid OMB coolrol number.
`
`STATEMENT UNDER 37 CFR 3.73{b}
`
`ApplicantJPatent Owner: John R. Plachetka
`···········-----.......... ------- -~--......... -----------
`Application No./Patent No. 1 0/158,21~_L6.9~§_,~~.!._ ________ _ Filed/Issue Date: May 31, 2002/ August 9, 2005
`---------
`
`----------~-
`
`Titled
`
`PHARMACEUTICAL COMPOSITIONS FOR THE COORDINATED DELIVERY OF NSAIDS
`
`POZEN, INC.
`
`(Name of Assignee)
`
`corporation
`
`.. ...... - -............. ----------·
`(Type of Assignee, e.g .. corporation, partnership. universit'f, government a-gency. etc
`
`1.
`
`the assignee of the entire nght, title, and interest in;
`
`states that it is:
`lg]
`2. n an assignee of less than the entire right. title, and mterest in
`3. n the assignee of an undivided interest in the entirety of (a complete assignment from one of the joint inventors was made)
`
`(The extent (by percentage) of its ownership interest is
`
`- - - -
`
`%): or
`
`the patent application/patent identified above, by virtue of either:
`
`OR
`B. 0
`
`An assignment from the inventor(s) of the patent application/patent identitied above. The assignment was recorded in
`, Frame 0958
`. or for which a
`the United States Patent and Trademark Office at Reel 013256
`copy therefore is attached,
`......
`
`A chain of title from the inventor(s), of the patent application/patent identified above. to the current assignee as follows:
`
`1. From:
`
`-~~---~--------------~~~-~~~~~-----~--~
`
`To.
`
`- - - -........... -------~~~--------~-----
`
`The document was recorded in the United States Patent and Trademark Office at
`
`Reel
`
`Frame
`
`or for which a copy thereof is attached.
`
`2. From:
`
`- - - - - - -.... -------------- · - - - -
`The document was recorded in the United States Patent and Trademark Office at
`
`To:
`
`Reel
`
`Frame ____________________ ~, or for INhich a copy thereof is attached.
`
`3. From:
`
`---~------------------- To:-~--~---------.. - - - - - - - - - - - -
`The document was recorded in the United States Patent and Trademark Office at
`Frame _______ _
`
`or for which a copy thereof is attached.
`
`Reel
`
`0
`
`Addittonal documents m the chain of title are listed on a supplemental sheet(s).
`
`As required by 37 CFR 3.73(b)(1)(!), the documentary evidence of the chain oftitle from the original owner to the assignee was,
`or concurrently is being, submitted for recordation pursLtant to 37 CFR 3.11.
`
`Signature
`
`August10,2012
`
`~~~----
`
`Date
`
`[NOTE: A separate copy (i.e., a true copy of the original assignment document(s)) must be submitted to Assignment Division in
`accordance with 37 CFR Part 3, to record the assigoment in the records of the USPTO. See MPEP 302.08]
`/\ ~
`The undersigned (whos~·titl~/}!5 supplied below) is authorized to act on behalf of the assignee.
`: k"i
`'~---.f/.'1-t/----~--------------.---------
`Steven L. Highlander; Rig. No. 37,642
`
`Attorney
`-------------------
`--~-----------i--+i-------~~-~
`Printed or T · .~d Name
`Title
`This co!!ection of information is required by 37 CFR 3,73{b). The Information is required to obtain or retain a benefit by the public which is to file (and by tne USPTO to
`process) an application. Confidentiality is govemed by 35 U.S. C .. 122 and 3 7 C FR 1. 11 and 1.14. This collection is estimated to take 12 mirJutes to complete, including
`gathering preparing, and submitting the completed application form to the USPTO. Ti.me will vaty depending up@ the individual case. Any comments on the amount of time
`you require to complete this forrn and/or suggestions for redudng this bwden, should be sent to the Chief Information Officer, U S. Patent and Trademark Office, U.S.
`Departme!1l of Commerce, P.O. Box 1450, Alex,;ndria, VA 22313-1450 .. 00 NOT SEND FEES OR COMPLETED FORMS TO 'fHIS ADDRESS. SEND TO: Commissioner
`for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`
`If you need assistance in completing the form, cali 1-800-PT0-9199 and select option 2,
`
`
`
`Page 9 of 613
`
`Patent Owner Ex. 2005
`CFAD v. Pozen
`IPR2015-01680
`
`

`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`APPLICATION NUMBER
`10/158,216
`
`FILING OR 3 71 (C) DATE
`05/31/2002
`
`66991
`LAW OFFICE OF MICHAEL A. SANZO, LLC
`15400 CALHOUN DR.
`SUITE 125
`ROCKVILLE, MD 20855
`
`UJ\TTED STI\TES DEPA RTME'IT OF COMMERCE
`United States Patent and Trademark Office
`Adill"'· COMMISSIO'JER FOR PATENTS
`PO Box 1450
`Alexandria, Vllgmia 22313-1450
`"W'.'Iw.uspto.gov
`
`FIRST NAMED APPLICANT
`John R. Plachetka
`
`ATTY. DOCKET NO./TITLE
`7569/73281
`CONFIRMATION NO. 5014
`POWER OF ATTORNEY NOTICE
`
`111111111111111111111111]~!1]~~~~~~~~~1~~ ~~~~~~1111111111111111111111111
`
`Date Mailed: 08/08/2011
`
`NOTICE REGARDING CHANGE OF POWER OF ATTORNEY
`
`This is in response to the Power of Attorney filed 07/29/2011.
`
`• The Power of Attorney to you in this application has been revoked by the assignee who has intervened as
`provided by 37 CFR 3.71. Future correspondence will be mailed to the new address of record(37 CFR 1.33).
`
`/hchristian/
`
`Office of Data Management, Application Assistance Unit (571) 272-4000, or (571) 272-4200, or 1-888-786-0101
`
`page 1 of 1
`
`
`
`Page 10 of 613
`
`Patent Owner Ex. 2005
`CFAD v. Pozen
`IPR2015-01680
`
`

`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`APPLICATION NUMBER
`10/158,216
`
`FILING OR 3 71 (C) DATE
`05/31/2002
`
`32425
`FULBRIGHT & JAWORSKI L.L.P.
`98 SAN JACINTO BOULEVARD
`SUITE 1100
`AUSTIN, TX 78701-4255
`
`UJ\TTED STI\TES DEPA RTME'IT OF COMMERCE
`United States Patent and Trademark Office
`Adill"'· COMMISSIO'JER FOR PATENTS
`PO Box 1450
`Alexandria, Vllgmia 22313-1450
`"W'.'Iw.uspto.gov
`
`FIRST NAMED APPLICANT
`John R. Plachetka
`
`ATTY. DOCKET NO./TITLE
`POZN.P0004US
`CONFIRMATION NO. 5014
`POA ACCEPTANCE LETTER
`
`111111111111111111111111]~!1]~~~~~~~~~1~~ ~IIJUIIIIIIIIIIIIIIIIIIIIIIIII
`
`Date Mailed: 08/08/2011
`
`NOTICE OF ACCEPTANCE OF POWER OF ATTORNEY
`
`This is in response to the Power of Attorney filed 07/29/2011.
`
`The Power of Attorney in this application is accepted. Correspondence in this application will be mailed to the
`above address as provided by 37 CFR 1.33.
`
`/hchristian/
`
`Office of Data Management, Application Assistance Unit (571) 272-4000, or (571) 272-4200, or 1-888-786-0101
`
`page 1 of 1
`
`
`
`Page 11 of 613
`
`Patent Owner Ex. 2005
`CFAD v. Pozen
`IPR2015-01680
`
`

`
`PTOISB/81 (01..06) MODIFIED
`Patent Number:
`6,926,907
`Issue Date:
`August 9, 2005
`Applleation Number:
`10/158,216
`May31, 2002
`FDlngDate:
`First Named Inventor:
`John R. PLACHETKA
`Attorney Docket Number:
`POZN.P0004US
`I bereby revoke all previous powers of attonaey givea in the above-ldentifted application.
`
`POWER OF AITORNEY
`AND
`CORRESPONDENCE ADDRESS
`INDICAnON FORM
`
`0 A Power of Attorney is submitted herewith.
`
`OR
`
`[8:1 I hereby appoint the practitioners associated with the Customer Number: 132425
`
`I
`
`as my/our attomey(s) or agent(s) to prosecute the application identified above, and to transact aU business in the
`United States Patent and Trademark Office connected therewith.
`
`Please recognize or change the correspondence address for the above-identified application to:
`
`[8:1 The address associated with Customer Number: 132425
`
`OR
`O_Firmor
`Individual Name
`
`Address
`
`City
`Country
`Telephone
`I am the:
`0 Applicant/Inventor.
`[8] Assignee of record of the entire interest. See 37 CFR 3.71.
`Statement under .3 7 CFR .3. 73(b) is enclosed. (Form PTOISB/96)
`
`I State I
`
`I Email
`
`I
`
`I Zip
`
`I
`
`Signature
`
`Name
`
`SIGNATURE OF APPUCANT OR ASSIGNEE OF RECORD
`
`d/2 I >Ji~~/1
`
`Gilda Thomas
`
`Title and Company
`
`Scmior Vice President, General Counsel
`POZBNJnc.
`
`Telephone
`
`Date
`
`7/7 /;;
`NOTB: Signatures of all the inventors or assignees of record of the entire interest or their representative(s) are required. Submit
`multiple forms if more than one signature is required, see below•.
`jgJ
`.-rotal of 1 fonn is submitted.
`
`95053175.1
`
`
`
`Page 12 of 613
`
`Patent Owner Ex. 2005
`CFAD v. Pozen
`IPR2015-01680
`
`

`
`Electronic Acknowledgement Receipt
`
`EFSID:
`
`Application Number:
`
`10631199
`
`10158216
`
`International Application Number:
`
`Confirmation Number:
`
`5014
`
`Title of Invention:
`
`PHARMACEUTICAL COMPOSITIONS FOR THE COORDINATED DELIVERY OF
`NSAIDS
`
`First Named Inventor/Applicant Name:
`
`John R. Plachetka
`
`Customer Number:
`
`66991
`
`Filer:
`
`Steven Lee Highlander/Tressie Bates
`
`Filer Authorized By:
`
`Steven Lee Highlander
`
`Attorney Docket Number:
`
`7569/73281
`
`Receipt Date:
`
`Filing Date:
`
`TimeStamp:
`
`29-JUL-2011
`
`31-MAY-2002
`
`16:17:40
`
`Application Type:
`
`Utility under 35 USC 111 (a)
`
`Payment information:
`
`Submitted with Payment
`
`I no
`
`File Listing:
`
`Document
`Number
`
`Document Description
`
`File Name
`
`File Size( Bytes)/
`Message Digest
`
`Multi
`Part /.zip
`
`Pages
`(ifappl.)
`
`702300
`
`1
`
`POZNP0004US-POA.pdf
`
`yes
`
`2
`
`bbcd22ae3cc7edbcda41 fb25cfd36138c9d
`e292f
`
`
`
`Page 13 of 613
`
`Patent Owner Ex. 2005
`CFAD v. Pozen
`IPR2015-01680
`
`

`
`Multipart Description/PDF files in .zip description
`
`Document Description
`
`Start
`
`End
`
`Assignee showing of ownership per 37 CFR 3.73(b).
`
`Power of Attorney
`
`1
`
`2
`
`1
`
`2
`
`Warnings:
`
`Information:
`
`Total Files Size (in bytes)
`
`702300
`
`This Acknowledgement Receipt evidences receipt on the noted date by the USPTO of the indicated documents,
`characterized by the applicant, and including page counts, where applicable. It serves as evidence of receipt similar to a
`Post Card, as described in MPEP 503.
`
`New A~~lications Under 35 U.S.C. 111
`If a new application is being filed and the application includes the necessary components for a filing date (see 37 CFR
`1.53(b)-(d) and MPEP 506), a Filing Receipt (37 CFR 1.54) will be issued in due course and the date shown on this
`Acknowledgement Receipt will establish the filing date of the application.
`
`National Stage of an International A~~lication under 35 U.S.C. 371
`If a timely submission to enter the national stage of an international application is compliant with the conditions of 35
`U.S.C. 371 and other applicable requirements a Form PCT/DO/E0/903 indicating acceptance of the application as a
`national stage submission under 35 U.S.C. 371 will be issued in addition to the Filing Receipt, in due course.
`
`New International A~~lication Filed with the USPTO as a Receiving Office
`If a new international application is being filed and the international application includes the necessary components for
`an international filing date (see PCT Article 11 and MPEP 181 0), a Notification of the International Application Number
`and of the International Filing Date (Form PCT/R0/1 OS) will be issued in due course, subject to prescriptions concerning
`national security, and the date shown on this Acknowledgement Receipt will establish the international filing date of
`the application.
`
`
`
`Page 14 of 613
`
`Patent Owner Ex. 2005
`CFAD v. Pozen
`IPR2015-01680
`
`

`
`PTO/SB/96 (07-09)
`Approved for use through 07/31/2012. OMB 0651-0031
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number
`
`STATEMENT UNDER 37 CFR 3.73(b)
`
`Applicant/Patent Owner: John R. PLACHETKA
`------------------------------------------------------------------------
`--------------------------------- Filed/Issue Date: August 9, 2005
`Application No./Patent No.: 6,926,907
`PHARMACEUTICAL COMPOSITIONS FOR THE COORDINATED DELIVERY OF NSAIDS
`
`--~-----------------------------
`
`Titled:
`
`POZEN INC.
`__________________________________________ ,a
`
`corporation
`
`(Name of Assignee)
`
`states that it is:
`
`1. ~ the assignee of the entire right, title, and interest in;
`
`(Type of Assignee, e.g., corporation, partnership, university, government agency, etc.
`
`2. D
`
`3. D
`
`an assignee of less than the entire right, title, and interest in
`(The extent (by percentage) of its ownership interest is ________ %);or
`
`the assignee of an undivided interest in the entirety of (a complete assignment from one of the joint inventors was made)
`
`the patent application/patent identified above, by virtue of either:
`[gj An assignment from the inventor(s) of the patent application/patent identified above. The assignment was recorded in
`, Frame 0958
`, or for which a
`the United States Patent and Trademark Office at Reel 013256
`copy therefore is attached.
`
`A.
`
`OR
`
`B. D A chain of title from the inventor(s), of the patent application/patent identified above, to the current assignee as follows:
`
`1. From:
`
`To: __________________________________ __
`
`The document was recorded in the United States Patent and Trademark Office at
`Reel -----------------' Frame ________________ , or for which a copy thereof is attached.
`To:
`
`2. From:
`
`3. From:
`
`The document was recorded in the United States Patent and Trademark Office at
`Reel -----------------' Frame ________________ , or for which a copy thereof is attached.
`To: -----------------------------------
`The document was recorded in the United States Patent and Trademark Office at
`Frame _________________ , or for which a copy thereof is attached.
`
`Reel ----------------- '
`
`Additional documents in the chain of title are listed on a supplemental sheet(s).
`
`D
`D As required by 37 CFR 3.73(b)(1 )(i), the documentary evidence of the chain of title from the original owner to the assignee was,
`
`or concurrently is being, submitted for recordation pursuant to 37 CFR 3.11.
`
`[NOTE: A separat copy (i.e., a true copy of the original assignment document(s)) must be submitted to Assignment Division in
`accordance with
`CFR Part 3, to record the assignment in the records of the USPTO. See MPEP 302.08)
`
`The undersigned ~ 1~e is supplied below) is authorized to act on behalf of the assignee.
`
`I ......._
`
`SignaturE
`
`Steven L. Highl ~dey-keg. No. 37,642
`
`July 29, 2011
`Date
`
`Attorney
`
`Printed or Typed Name
`Title
`This collection of information is required by 37 CFR 3. 73(b). The information is required to obtain or retain a benefit by the public which is to file (and by the USPTO to
`process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.11 and 1.14. This collection is estimated to take 12 minutes to complete, including
`gathering, preparing, and submitting the completed application form to the USPTO. Time will vary depending upon the individual case. Any comments on the amount of time
`you require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and Trademark Office, U.S.
`Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner
`for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`
`If you need assistance in completing the form, ca/11-800-PT0-9199 and select option 2.
`
`
`
`Page 15 of 613
`
`Patent Owner Ex. 2005
`CFAD v. Pozen
`IPR2015-01680
`
`

`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`CERTIFICATE OF CORRECTION
`
`PATENT NO.
`: 6,926,907 B2
`APPLICATION NO. : 10/158216
`DATED
`: August 9, 2005
`INVENTOR(S)
`: John Plachetka
`
`Page 1 of 3
`
`It is certified that error appears in the above-identified patent and that said Letters Patent is
`hereby corrected as shown below:
`
`In the flrst line of claim 1 line 1 in the issued patent, the word "dose" should
`
`be --dosage.-- Thus, the correct claim should read as follows:
`
`Col. 20, Claim
`
`1.
`
`A pharmaceutical composition in unit dosage form suitable for oral
`
`administration to a patient, comprising: (a) an acid inhibitor present in an
`
`amount effective to raise the gastric pH of said patient to at least 3.5 upon the
`
`administration of one or more of said unit dosage forms; (b) a non-steroidal
`
`anti-inflammatory drug (NSAID) in an amount effective to reduce or eliminate
`
`pain or inflammation in said patient upon administration of one or more of said
`
`unit dosage forms;
`
`and wherein said unit dosage form provides for coordinated release such that:
`
`i) said NSAID is surrounded by a coating that, upon ingestion of said unit
`
`dosage form by said patient, prevents the release of essentially any NSAID from
`
`said dosage form unless the pH of the surrounding medium is 3.5 or higher; ii)
`
`at least a portion of said acid inhibitor is not surrounded by an enteric coating
`
`and, upon ingestion of said unit dosage form by said patient, is released
`
`regardless of whether the pH of the surrounding medium is below 3.5 or above
`
`3.5.
`
`
`
`Page 16 of 613
`
`Patent Owner Ex. 2005
`CFAD v. Pozen
`IPR2015-01680
`
`

`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`CERTIFICATE OF CORRECTION
`
`: 6,926,907 B2
`PATENT NO.
`APPLICATIONNO. : 10/158216
`DATED
`:August 9, 2005
`: John Plachetka
`INVENTOR(S)
`
`Page2 of 3
`
`It is certified that error appears in the above-identified patent and that said Letters Patent is
`hereby corrected as shown below:
`
`Col. 21, Line 1 of claim 16 and 17 should refer to "any one of claims 12-14" and
`
`not to "claim 15." In addition, the phrase --wherein said acid inhibitor is a proton pump
`
`inhibitor-- should be included in 16 and 17. Thus, the claims should read as follows:
`
`Col. 21
`
`16. The pharmaceutical composition of any one of claims 12-14, wherein said acid
`
`inhibitor is a proton pump inhibitor and wherein said coating surrounding said
`
`core does not dissolve unless the pH of the surrounding medium is 4 or greater.
`
`1 7. The pharmaceutical composition of any one of claims 12-14, wherein said acid
`
`inhibitor is a proton pump inhibitor and wherein said coating surrounding said
`
`core does not dissolve unless the pH of the surrounding medium is 5 or greater.
`
`Col. 21, Line 1 of claims 19 and 20 should refer to "any one of claims 12-14" and
`
`not to "claim 18." In addition, the phrase --wherein said acid inhibitor is an H2
`
`blocker-- should be included in 19 and 20. Thus, the claims should read as
`follows:
`
`Col. 21
`
`19. The pharmaceutical composition of any one of claims 12-14, wherein said acid
`
`inhibitor is an H2 blocker and wherein said ta